Recent Advances in Regenerative Pharmacology

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".

Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 551

Special Issue Editors

Prof. Dr. Bin Duan
E-Mail Website
Guest Editor
Mary and Dick Holland Regenerative Medicine Program, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: biomaterials; 3D bioprinting and tissue engineering and regenerative medicine
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Street, Changchun 130022, China
Interests: polymer chemistry; self-assembly; nanoparticle; hydrogel; scaffold; biomaterial; controlled drug delivery; immunotherapy; regenerative medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Regenerative medicine is an emerging multidisciplinary field that aims to restore the physiological functions of damaged/diseased human cells, tissues, or organs. Many cellular, genetic, engineering, and clinical strategies have been used to improve therapeutic efficacy. Pharmaceutical agents and biotechnologies play an important role in regulating cell, tissue, and organ functions to prevent the progression of diseases or enhance regeneration outcomes. The intent of this Special Issue is to cover recent advances in the fields of regenerative medicine and pharmacology for driving future innovations and collaborations, developing curative therapeutics, and improving patient quality of life. This Special Issue will focus on the implementation of pharmaceutical agents, administrated alone or in combination with biomaterials, cells, or biomedical devices to achieve enhanced regeneration outcomes in vitro and/or in vivo.

Original submissions as research articles, perspectives, or review articles are all welcome. The proposed topics include, but are not limited to: design and preparation of regenerative medicine biomaterials; biofabrication or 3D printing in pharmaceutical product design; advanced biomaterials for controlled drug delivery; unique scaffolds for target delivery of bioactive agents; effects of therapeutics on stem cell, organoid, or engineered tissue maintenance, differentiation, and functions;  engineered constructs for various tissue regeneration; biotechnology or therapeutic for stimulating endogenous tissue regeneration.

Prof. Dr. Bin Duan
Prof. Dr. Jianxun Ding
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomaterial
  • therapeutic agent
  • advanced pharmaceutical
  • control release
  • stem cell therapy
  • tissue regeneration
  • tissue engineering
  • function recovery

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop